COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Carol Hamelink

Dr. Carol Hamelink

Scientific Review Officer


Division of Neuroscience, Development and Aging DNDA
Molecular, Cellular and Developmental Neuroscience MDCN
Study Section:
Neural Oxidative Metabolism and Death NOMD

Dr. Carol Hamelink serves as the Scientific Review Officer for CSR’s Neural Oxidative Metabolism and cell Death study section.

Dr. Hamelink received her Ph.D. in nutrition from the University of Maryland College Park. Her research there focused on the neurodegenerative effects of alcohol consumption on the hippocampus. Subsequently, she was a postdoctoral research fellow at the National Institute of Mental Health, where she worked in the Laboratory of Cellular and Molecular Regulation studying the protective effects of pituitary adenylate cyclase activating polypeptide (PACAP) in pathophysiological stress.